SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
66.50    6.50 (10.83%)
Bid:
65.00
Ask:
68.00
Spread: 3.00 (4.615%)
Market Cap: £52.41m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Year End Trading Update

22 Oct 2025 07:00

RNS Number : 2881E
Hardide PLC
22 October 2025
 

 

Hardide plc

("Hardide", the "Group" or the "Company")

Year end trading update

 

 

Hardide plc (AIM: HDD), the developer and provider of advanced surface coating technology, is pleased to provide a pre-close trading update for the financial year ended 30 September 2025 ("FY25").

 

Revenues grew by over 25% to £6.0m (FY24: £4.7m), driven by the new recurring work in the aerospace sector announced in the early part of the year and new development work won more recently in the energy sector.

 

The Board expects this growth to deliver a materially improved EBITDA result for the year of approximately £1m (FY24: break-even*) at an EBITDA margin of over 16%, together with a positive earnings per share outcome for the first time in many years.

 

The Group's net debt (including leases) at 30 September 2025 was £1.6m (30 September 2024: £2.1m). Within this, the cash balance was £0.8m compared with £0.7m a year ago, despite some working capital absorption ahead of the financial year end due to strong trading in the final quarter. This included initial development work with new customers in North America and the Middle East within the energy sector.

 

Whilst mindful of continuing global economic uncertainties, the Board remains confident in the Group's prospects, supported by increasing market adoption of Hardide's unique surface coating technology. 

 

The Board remains highly focused on delivering its medium-term objective to double revenues from FY24 levels to at least £10m over the next few years, leveraging existing spare capacity to drive significant operating margin and earnings growth.

 

Notes:

The Group expects to announce its full audited annual results for FY25 in late January 2026. All figures relating to FY25 provided above are unaudited.

 

*Prior to one-off restructuring costs of £0.4m in FY24

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

Enquiries:

 

Hardide plc

Matt Hamblin (Chief Executive Officer)

Tel: +44 (0) 1869 353 830

Simon Hallam (Chief Financial Officer)

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson / Elysia Bough (Corporate Finance)

Tel: +44 (0) 2072 200 500

Jasper Berry / Dale Bellis (Sales)

Notes to editors:

www.Hardide.com

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDIELLFIE
Date   Source Headline
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components
8th Jul 20197:00 amRNSContract Award
28th Jun 20197:00 amRNSExercise of Options and Director Shareholdings
11th Jun 20195:00 pmRNSHolding(s) in Company
14th May 20197:00 amRNSInterim Results
14th May 20197:00 amRNSHardide selected for Airbus A380 wing components
13th Mar 20197:00 amRNSHardide Coating Extends Life of Turbine Blades
7th Mar 201911:37 amRNSHolding(s) in Company
7th Mar 201911:36 amRNSHolding(s) in Company
4th Mar 20193:16 pmRNSResult of AGM and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.